Literature DB >> 29597005

Non-syndromic retinitis pigmentosa.

Sanne K Verbakel1, Ramon A C van Huet1, Camiel J F Boon2, Anneke I den Hollander3, Rob W J Collin4, Caroline C W Klaver5, Carel B Hoyng1, Ronald Roepman6, B Jeroen Klevering7.   

Abstract

Retinitis pigmentosa (RP) encompasses a group of inherited retinal dystrophies characterized by the primary degeneration of rod and cone photoreceptors. RP is a leading cause of visual disability, with a worldwide prevalence of 1:4000. Although the majority of RP cases are non-syndromic, 20-30% of patients with RP also have an associated non-ocular condition. RP typically manifests with night blindness in adolescence, followed by concentric visual field loss, reflecting the principal dysfunction of rod photoreceptors; central vision loss occurs later in life due to cone dysfunction. Photoreceptor function measured with an electroretinogram is markedly reduced or even absent. Optical coherence tomography (OCT) and fundus autofluorescence (FAF) imaging show a progressive loss of outer retinal layers and altered lipofuscin distribution in a characteristic pattern. Over the past three decades, a vast number of disease-causing variants in more than 80 genes have been associated with non-syndromic RP. The wide heterogeneity of RP makes it challenging to describe the clinical findings and pathogenesis. In this review, we provide a comprehensive overview of the clinical characteristics of RP specific to genetically defined patient subsets. We supply a unique atlas with color fundus photographs of most RP subtypes, and we discuss the relevant considerations with respect to differential diagnoses. In addition, we discuss the genes involved in the pathogenesis of RP, as well as the retinal processes that are affected by pathogenic mutations in these genes. Finally, we review management strategies for patients with RP, including counseling, visual rehabilitation, and current and emerging therapeutic options.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Genotype-phenotype correlation; Inherited retinal dystrophy; Phenotype; RP subtype; Retinitis pigmentosa; Rod-cone dystrophy

Mesh:

Substances:

Year:  2018        PMID: 29597005     DOI: 10.1016/j.preteyeres.2018.03.005

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  178 in total

Review 1.  The primary cilium: Its role as a tumor suppressor organelle.

Authors:  Estanislao Peixoto; Seth Richard; Kishor Pant; Aalekhya Biswas; Sergio A Gradilone
Journal:  Biochem Pharmacol       Date:  2020-03-10       Impact factor: 5.858

2.  Novel REEP6 gene mutation associated with autosomal recessive retinitis pigmentosa.

Authors:  Yuchen Lin; Christine L Xu; Gabriel Velez; Jing Yang; Akemi J Tanaka; Mark P Breazzano; Vinit B Mahajan; Janet R Sparrow; Stephen H Tsang
Journal:  Doc Ophthalmol       Date:  2019-09-19       Impact factor: 2.379

Review 3.  Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.

Authors:  Frans P M Cremers; Winston Lee; Rob W J Collin; Rando Allikmets
Journal:  Prog Retin Eye Res       Date:  2020-04-09       Impact factor: 21.198

4.  Projection-Resolved Optical Coherence Tomographic Angiography of Retinal Plexuses in Retinitis Pigmentosa.

Authors:  Ahmed M Hagag; Jie Wang; Kevin Lu; Gareth Harman; Richard G Weleber; David Huang; Paul Yang; Mark E Pennesi; Yali Jia
Journal:  Am J Ophthalmol       Date:  2019-03-06       Impact factor: 5.258

5.  RNA Splicing Factor Mutations That Cause Retinitis Pigmentosa Result in Circadian Dysregulation.

Authors:  Iryna Shakhmantsir; Scott J Dooley; Siddharth Kishore; Dechun Chen; Eric Pierce; Jean Bennett; Amita Sehgal
Journal:  J Biol Rhythms       Date:  2019-11-15       Impact factor: 3.182

Review 6.  A Systematic Review and Meta-Analyses of Interventional Clinical Trial Studies for Gene Therapies for the Inherited Retinal Degenerations (IRDs).

Authors:  Gearóid P Tuohy; Roly Megaw
Journal:  Biomolecules       Date:  2021-05-19

Review 7.  Retinal stem cell transplantation: Balancing safety and potential.

Authors:  Mandeep S Singh; Susanna S Park; Thomas A Albini; M Valeria Canto-Soler; Henry Klassen; Robert E MacLaren; Masayo Takahashi; Aaron Nagiel; Steven D Schwartz; Kapil Bharti
Journal:  Prog Retin Eye Res       Date:  2019-09-05       Impact factor: 21.198

Review 8.  Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.

Authors:  Alexandra V Garafalo; Artur V Cideciyan; Elise Héon; Rebecca Sheplock; Alexander Pearson; Caberry WeiYang Yu; Alexander Sumaroka; Gustavo D Aguirre; Samuel G Jacobson
Journal:  Prog Retin Eye Res       Date:  2019-12-30       Impact factor: 21.198

9.  Monitoring progression of retinitis pigmentosa: current recommendations and recent advances.

Authors:  Moreno Menghini; Jasmina Cehajic-Kapetanovic; Robert E MacLaren
Journal:  Expert Opin Orphan Drugs       Date:  2020-03-02       Impact factor: 0.694

10.  A mutation in CRX causing pigmented paravenous retinochoroidal atrophy.

Authors:  Jin Kyun Oh; Yan Nuzbrokh; Winston Lee; Jose Ronaldo Lima de Carvalho; Nan Kai Wang; Janet R Sparrow; Rando Allikmets; Stephen H Tsang
Journal:  Eur J Ophthalmol       Date:  2020-09-14       Impact factor: 2.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.